The short answer — and why it depends

Yes — for the right patient, cartilage repair can demonstrably delay a knee replacement, and in some cases help avoid one altogether. The caveat matters, though, and it shapes everything that follows.

The strongest long-term evidence comes from MACI (matrix-induced autologous chondrocyte implantation): a systematic review covering more than ten years of follow-up found that only 7.4% of treated patients went on to total knee arthroplasty. That means roughly nine in ten retained their natural knee for over a decade after repair — a meaningful result when the alternative for many of those patients would have been early joint replacement.

Autologous chondrocyte implantation (ACI) is described in peer-reviewed literature as 'slowing or considerably delaying partial or total joint replacement surgery' — language that captures the realistic ambition of these procedures without overstating it.

The answer is conditional because cartilage repair and knee replacement are solutions to different clinical problems. Repair works when the damage is focal and isolated — a discrete lesion in an otherwise functional joint. Diffuse, bone-on-bone osteoarthritis spanning most of the joint surface is a different matter, and one where replacement is usually the more appropriate path.

Age and activity level add a further dimension. Knee replacement implants are expected to last 15–20 years, which means a patient in their forties or fifties who undergoes replacement today faces a high probability of revision surgery later in life. For that group, buying a decade or more through joint preservation is not a compromise — it is often the sounder long-term strategy.

Why cartilage damage doesn't heal on its own

Damaged articular cartilage stays damaged because it has no blood supply. Most injured tissue heals through the vascular system — clotting, inflammation, and cellular repair arriving via the bloodstream. Cartilage has none of that infrastructure. Once a section is lost or worn through, the body has no reliable way to restore it.

Left untreated, a focal defect does not simply stay the same size. Exposed subchondral bone and uneven load distribution accelerate wear in the surrounding tissue, and what begins as a contained lesion tends to expand over time. Long-term follow-up data make the consequence clear: fragment excision without structural restoration is associated with a high subsequent rate of osteoarthritis, which reinforces the clinical case for repair rather than debridement alone.

Surgical repair is therefore not optional enhancement — it is filling a gap the body cannot fill. The three principal strategies differ in what they put there. Marrow stimulation techniques (such as microfracture) perforate the bone beneath the defect to release progenitor cells, producing a repair tissue called fibrocartilage. Cell-based methods, ACI and MACI, aim to regenerate tissue closer in character to native hyaline cartilage. Osteochondral transfer (OATS) transplants an intact bone-and-cartilage plug from an undamaged part of the joint.

The distinction between fibrocartilage and hyaline cartilage matters clinically: fibrocartilage is mechanically inferior and tends to deteriorate within two to three years, which is why microfracture has largely given way to more durable approaches for suitable patients.

Who is a candidate for repair rather than replacement

Three questions generally determine whether cartilage repair belongs on the table — and the most important one concerns the pattern of damage, not its severity.

Is the damage focal or diffuse? A discrete, contained lesion in an otherwise healthy joint is what cartilage repair is designed for. Widespread osteoarthritis affecting bone across the whole joint surface sits outside that scope; the two conditions represent different clinical problems, and treating diffuse bone-on-bone disease with a focal repair technique is unlikely to produce meaningful or lasting benefit. In those cases, joint replacement remains the more appropriate pathway.

How old is the patient, and how active? Younger, active individuals gain the most from repair. The delay in joint replacement is proportionally longer, the subchondral bone is better conditioned to support healing, and recovery capacity is generally greater. Given that knee replacement implants carry a 15–20 year service expectancy, a patient in their forties who undergoes replacement now faces near-certain revision surgery later — a strong argument for attempting preservation first where the joint permits it.

Is leg alignment normal? Malalignment concentrates load on whichever compartment is being repaired and can cause the procedure to fail even when the repair itself is technically sound. Where significant malalignment is present, a corrective osteotomy — high tibial osteotomy (HTO) to unload the inner compartment, or distal femoral osteotomy (DFO) for the outer — may need to accompany the cartilage work. These are joint-preservation procedures in their own right, not cartilage repairs, but they protect the repaired site by redistributing mechanical stress.

Defect size also matters practically: smaller lesions may suit single-stage or minimally invasive approaches, whilst mid-range and larger defects typically call for cell-based or allograft techniques. That mapping is covered in the next section.

How the main repair techniques differ — and what the TKA-delay evidence shows

The techniques available span a wide range of invasiveness and biological complexity; what suits one patient's defect may be entirely wrong for another's. Selecting the right approach is a specialist decision shaped by defect size, location, depth, and individual patient factors — what follows is a map of the landscape, not a self-selection guide.

ChondroFiller injection sits at the least invasive end of the current-service pathway: an acellular collagen scaffold delivered via ultrasound-guided injection as an outpatient procedure, without theatre or general anaesthetic. Once placed, it recruits the patient's own progenitor cells to the defect site through matrix-induced chondrogenesis — making it a regenerative option for suitable focal lesions rather than simply a symptom-management measure.

AMIC (autologous matrix-induced chondrogenesis) is a single-stage surgical procedure that layers a scaffold over a microfracture site, retaining the released progenitor cells and improving the quality of the resulting repair tissue. It bridges the gap between simple marrow stimulation and the more resource-intensive cell-based techniques.

OATS and mosaicplasty transfer healthy osteochondral plugs from a low-load zone of the knee into the defect. Ten-year comparative data (Gudas, 2012) support better durability over microfracture alone for lesions in the 1–2 cm² range; a mosaicplasty pattern can extend coverage to around 4 cm². Donor-site morbidity — the possibility of long-term symptoms at the harvest site — is a genuine consideration that our consultants discuss at the planning stage.

Microfracture retains a historical reference point but is no longer a first-line modern choice. Beyond the fibrocartilage quality concerns described in the previous section, current evidence highlights subchondral bone plate damage that can compromise any subsequent repair — a practical reason why scaffold-augmented and cell-based options have largely replaced it for suitable candidates.

ACI and MACI are the two-stage cell-based techniques, producing tissue closer in character to native hyaline cartilage than fibrocartilage alternatives. Published series report 85–90% patient satisfaction in appropriate candidates. Long-term MACI follow-up extending beyond ten years confirms that the substantial majority of treated patients avoided replacement altogether — the strongest TKA-delay evidence in this group. It is also worth noting that ACI shows higher failure rates when prior marrow-stimulation procedures have already been performed.

STACI (next-generation ACI) aims to collapse the two-stage process into a single procedure. Early results are promising, but clinical evidence remains limited and our consultants would present it as an emerging option rather than an established pathway.

Recovery timeline and what 'success' realistically means

Patience is not optional. Articular cartilage matures slowly, and published data put the full tissue healing window at 9–18 months; formal rehabilitation — strengthening the surrounding muscles and gradually reloading the joint — typically runs for 4–6 months of that period. Patients who enter a repair programme expecting a six-week turnaround are likely to be disappointed.

The timeline is not identical across techniques. Outpatient injectable scaffold pathways such as ChondroFiller injection carry shorter initial downtime than two-stage cell-based procedures like ACI or MACI, where the biopsy stage, laboratory culture period, and re-implantation are separated by weeks. If a corrective osteotomy is required alongside the cartilage work, that adds operative complexity and its own recovery phase.

What does success actually look like? The most honest framing is a bridge strategy: in the right patient, repair can delay osteoarthritis progression and postpone joint replacement by a decade or more — the MACI systematic review with over ten years of follow-up found only 7.4% of patients went on to TKA. Preserving the natural joint also matters in a way that is difficult to quantify on a satisfaction scale; patients frequently report a more natural feel of movement than an implant provides, which carries real value for those who want to remain active.

What repair does not do is guarantee permanent prevention of arthritis. The condition may progress, and a future replacement may still be necessary — but on a timetable measured in years rather than the immediate one that would apply without intervention.

When replacement is the right answer — and where to go next

Not every knee is a candidate for joint preservation, and a specialist team is as likely to say so honestly as to recommend repair. When osteoarthritis involves multiple compartments with significant bone loss and a patient's activity demands are modest, replacement is generally the more appropriate route — and there is no clinical value in delaying a necessary TKR to pursue repair that the joint cannot sustain.

The harder question, in practice, is which side of that line a specific patient sits on. Answering it requires imaging — ideally weight-bearing MRI or standing X-ray to assess joint-line narrowing across all three compartments — alongside a clear picture of activity goals, alignment, and how much healthy cartilage remains in the surrounding areas. Knowing those answers before making a decision is what separates a well-planned pathway from an unnecessary delay in either direction.

MSK Doctors accepts patients for consultant assessment without a GP referral; London-based patients can access the same specialist pathway through the London Cartilage Clinic. Appointments can be booked at mskdoctors.com.

1. [1] Autologous chondrocyte implantation – Wikipedia. https://en.wikipedia.org/?curid=19074150 https://en.wikipedia.org/?curid=19074150
2. [2] Knee cartilage replacement therapy – Wikipedia. https://en.wikipedia.org/?curid=4984243 https://en.wikipedia.org/?curid=4984243
3. [3] Knee replacement – Wikipedia. https://en.wikipedia.org/?curid=2830398 https://en.wikipedia.org/?curid=2830398